Identification and Verification of Molecular Subtypes with Enhanced Immune Infiltration Based on m6A Regulators in Cutaneous Melanoma

Table 2

Different CNV patterns occur in CM patients.

Types	Genes	Diploid	Deletion	Amplification	CNV sum	Amplification (%)	Deletion (%)	Percentage
Writers	METTL3	338	93	40	133	30.08%	69.92%	28.24%
	METTL14	354	76	41	117	35.04%	64.96%	24.84%
	WTAP	203	246	24	270	8.89%	91.11%	57.08%
	KIAA1429	268	10	194	204	95.10%	4.90%	43.22%
	RBM15	236	70	75	145	51.72%	48.28%	38.06%
	ZC3H13	303	76	92	168	54.76%	45.24%	35.67%
Readers	YTHDC1	361	68	52	120	43.33%	56.67%	24.95%
	YTHDC2	324	100	47	147	31.97%	68.03%	31.21%
	YTHDF3	282	14	175	189	92.59%	7.41%	40.13%
	YTHDF1	271	3	198	201	98.51%	1.49%	42.58%
	YTHDF2	346	55	70	125	56.00%	44.00%	26.54%
	HNRNPC	338	93	40	133	30.08%	69.92%	28.24%
	IGF2BP1	3342	43	90	133	67.67%	32.33%	3.83%
	IGF2BP2	358	51	62	113	54.87%	45.13%	23.99%
	IGF2BP3	228	18	230	248	92.74%	7.26%	52.10%
Erasers	FTO	329	116	36	152	23.68%	76.32%	31.60%
	ALKBH5	336	209	26	235	11.06%	88.94%	41.16%
Total		8217	1341	1492	2833	52.67%	47.33%	25.64%